The effects of Telmisartan, an angiotensinII type 1 receptor blocker, in reducing AAA growth in patients with abdominal aortic aneurysm.
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Telmisartan (Primary)
- Indications Aneurysm
- Focus Therapeutic Use
- Acronyms TEDY
- 15 Sep 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 03 Apr 2017 Planned End Date changed from 1 Aug 2016 to 1 Aug 2017.